Literature DB >> 3489620

In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.

K Yanai, T Ido, K Ishiwata, J Hatazawa, T Takahashi, R Iwata, T Matsuzawa.   

Abstract

The endogenous hallucinogen, N,N-dimethyltryptamine (DMT), was labeled with carbon-11 and its regional distribution in rat brain studied. [11C]DMT showed higher accumulation in the cerebral cortex, caudate putamen, and amygdaloid nuclei. Studies of the subcellular distribution of [11C]DMT revealed the specific localization in the fractions enriched with serotonin receptors only when a very low dose was injected into rats. The proportions of the radioactivity in receptor-rich fractions were greatly enhanced by pretreatment with the monoamine oxidase inhibitor, pargyline. Specific binding of [11C]DMT to serotonin receptors in dog brain was demonstrated by a positron emission tomographic study in which 5-methoxy-N,N-dimethyltryptamine caused approximately 20% displacement of the radioligand from the receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489620     DOI: 10.1007/BF00276707

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.

Authors:  N Narasimhachari; H E Himwich
Journal:  Biochem Biophys Res Commun       Date:  1973-12-19       Impact factor: 3.575

2.  Serotonergic component of neuroleptic receptors.

Authors:  J E Leysen; C J Niemegeers; J P Tollenaere; P M Laduron
Journal:  Nature       Date:  1978-03-09       Impact factor: 49.962

3.  Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates.

Authors:  S A Barker; J A Monti; S T Christian
Journal:  Biochem Pharmacol       Date:  1980-04-01       Impact factor: 5.858

4.  Accumulation of N,N-dimethyltryptamine in rat brain cortical slices.

Authors:  S Sangiah; M V Gomez; E F Domino
Journal:  Biol Psychiatry       Date:  1979-12       Impact factor: 13.382

5.  Quantitative autoradiography of serotonin receptors in the rat brain.

Authors:  A Biegon; T C Rainbow; B S McEwen
Journal:  Brain Res       Date:  1982-06-24       Impact factor: 3.252

6.  Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.

Authors:  J P Bennett; S H snyder
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

7.  High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding.

Authors:  G M Fillion; J C Rousselle; M P Fillion; D M Beaudoin; M R Goiny; J M Deniau; J J Jacob
Journal:  Mol Pharmacol       Date:  1978-01       Impact factor: 4.436

8.  Carbon 11 labeling of the psychoactive drug o-methyl-bufotenine and its distribution in the animal organism.

Authors:  G Berger; M Mazière; C Marazano; D Comar
Journal:  Eur J Nucl Med       Date:  1978-04-01

9.  Biodistribution of a positron-emitting suicide inactivator of monoamine oxidase, carbon-11 pargyline, in mice and a rabbit.

Authors:  K Ishiwata; T Ido; K Yanai; K Kawashima; Y Miura; M Monma; S Watanuki; T Takahashi; R Iwata
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

10.  The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.

Authors:  J C Gillin; J Kaplan; R Stillman; R J Wyatt
Journal:  Am J Psychiatry       Date:  1976-02       Impact factor: 18.112

View more
  7 in total

Review 1.  A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.

Authors:  Ede Frecska; Attila Szabo; Michael J Winkelman; Luis E Luna; Dennis J McKenna
Journal:  J Neural Transm (Vienna)       Date:  2013-04-26       Impact factor: 3.575

Review 2.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

3.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Authors:  Nicholas V Cozzi; Anupama Gopalakrishnan; Lyndsey L Anderson; Joel T Feih; Alexander T Shulgin; Paul F Daley; Arnold E Ruoho
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

4.  Investigation of the Structure-Activity Relationships of Psilocybin Analogues.

Authors:  Adam K Klein; Muhammad Chatha; Lauren J Laskowski; Emilie I Anderson; Simon D Brandt; Stephen J Chapman; John D McCorvy; Adam L Halberstadt
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-14

5.  Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.

Authors:  Calvin Ly; Alexandra C Greb; Maxemiliano V Vargas; Whitney C Duim; Ana Cristina G Grodzki; Pamela J Lein; David E Olson
Journal:  ACS Pharmacol Transl Sci       Date:  2020-09-11

6.  A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.

Authors:  Andrew R Gallimore; Rick J Strassman
Journal:  Front Pharmacol       Date:  2016-07-14       Impact factor: 5.810

Review 7.  Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine.

Authors:  Jon G Dean
Journal:  Front Neurosci       Date:  2018-04-23       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.